Long Term Metabolic and Inflammatory Effects of Second-Generation Antipsychotics: A Study in Mentally Disordered Offenders

Long Term Metabolic and Inflammatory Effects of Second-Generation Antipsychotics: A Study in Mentally Disordered Offenders

Mentally disordered offenders provided with forensic psychiatric care are often treated with second generation antipsychotic (SGA) medication and experience metabolic and inflammatory side effects. Aim: In this paper, we monitored the three-year fluctuation of selected anthropometric, biochemical, a...

Full description

Bibliographic Details
Main Authors:	Emilia Vassilopoulou, Dimitris Efthymiou, Evangelia Papatriantafyllou, Maria Markopoulou, Efthymia-Maria Sakellariou, Alina Codruta Popescu
Format:	Article
Language:	English
Published:	MDPI AG 2021-11-01
Series:	Journal of Personalized Medicine
Subjects:	forensic psychiatry antipsychotic drugs metabolic disturbances
Online Access:	https://www.mdpi.com/2075-4426/11/11/1189

Similar Items

The Effects of Use of Long-Term Second-Generation Antipsychotics on Liver and Kidney Function: A Prospective Study
by: Evangelia Papatriantafyllou, et al.
Published: (2022-07-01)

Nationwide study on antipsychotic polypharmacy among forensic psychiatric patients
by: Stine Lassen, et al.
Published: (2023-12-01)

The Prevalence and Factors Associated With Antipsychotic Polypharmacy in a Forensic Psychiatric Sample
by: Christian Farrell, et al.
Published: (2020-04-01)

High Risk, High Dose?—Pharmacotherapeutic Prescription Patterns of Offender and Non-Offender Patients with Schizophrenia Spectrum Disorder
by: Lena Machetanz, et al.
Published: (2022-12-01)

Antipsychotic factors related to time to competency for forensic inpatients in a state psychiatric facility
by: Amber Lemons, PharmD, BCPP, et al.
Published: (2022-06-01)

Adverse health events associated with antipsychotic use: an umbrella review
by: Chow, RTS
Published: (2021)

Gait Alterations in the Prediction of Metabolic Syndrome in Patients With Schizophrenia: A Pilot Study With PODOSmart ® Insoles
by: Dimitris Efthymiou, et al.
Published: (2022-01-01)

Sleep Deprivation: Effects on Weight Loss and Weight Loss Maintenance
by: Evangelia Papatriantafyllou, et al.
Published: (2022-04-01)

Second-generation antipsychotic medications and metabolic disturbance in children and adolescents
by: Samy Makary, et al.
Published: (2023-01-01)

Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review
by: Solmi M, et al.
Published: (2017-06-01)

Probation of the offender with high functioning autistic traits and comorbidity. A case study
by: A. Riolo, et al.
Published: (2021-04-01)

Antipsychotics in child and adolescent patients with major depressive disorder: A retrospective analysis of prescribing patterns
by: Danielle Dauchot, PharmD, et al.
Published: (2024-02-01)

Blood and Urinary Biomarkers of Antipsychotic-Induced Metabolic Syndrome
by: Aiperi K. Khasanova, et al.
Published: (2022-08-01)

Trends in antipsychotic use among children and adolescents in Germany: a study using 2011–2020 nationwide outpatient claims data
by: Michael Dörks, et al.
Published: (2023-12-01)

The Burden of Antipsychotic-Induced Weight Gain and Metabolic Syndrome in Children
by: Mark R. Libowitz, et al.
Published: (2021-03-01)

The Toxicity Potential of Antidepressants and Antipsychotics in Relation to Other Medication and Alcohol: A Naturalistic and Retrospective Study
by: Marleen M. M. Swoboda, et al.
Published: (2022-05-01)

Integrative Analyses of Transcriptomes to Explore Common Molecular Effects of Antipsychotic Drugs
by: Trang T. T. Truong, et al.
Published: (2022-07-01)

An intercultural perspective toward supporting antipsychotic medication adherence in clinical practice
by: Tharun Zacharia
Published: (2023-02-01)

Antipsychotic Polypharmacy and High-Dose Antipsychotic Regimens in the Residential Italian Forensic Psychiatric Population (REMS)
by: Gabriele Mandarelli, et al.
Published: (2022-02-01)

Off-label prescribing of antipsychotics in a Danish child and adolescent mental health center: A register-based study
by: Kristine Tofting Korno, et al.
Published: (2018-01-01)

Gender Differences in the Psychopharmacological Treatment of Forensic In-Patients With Schizophrenia
by: Juliane Mayer, et al.
Published: (2022-07-01)

Second generation antipsychotics causing neuroleptic malignant syndrome
by: C. Suraweera, et al.
Published: (2016-12-01)

Onset of Action of Selected Second-Generation Antipsychotics (Pines)–A Systematic Review and Meta-Analyses
by: Rikke Meyer, et al.
Published: (2022-12-01)

Eye tracking and child sexual offenders: a systematic review
by: Tony Godet, et al.
Published: (2021-04-01)

Safer communities; how the first forensic community mental health team helped improve mental health, battle stigma, and reduce offending
by: M.H. Siddiqui, et al.
Published: (2022-06-01)

The reconvictions of mentally disordered offenders—how, when, and where?
by: Ebba Noland, et al.
Published: (2022-04-01)

Clinical use of second-generation antipsychotics in children
by: Kirsi Kakko, et al.
Published: (2017-10-01)

Dimensional assessment of psychopathy and relationship with physiological response to empathic images in juvenile offenders
by: Daniel M Barros, et al.
Published: (2013-11-01)

Pharmacogenetics and Schizophrenia—Can Genomics Improve the Treatment with Second-Generation Antipsychotics?
by: Olga Płaza, et al.
Published: (2022-12-01)

Second-generation antipsychotic and diabetes mellitus in children and adolescents
by: Carlo Ripoli, et al.
Published: (2017-12-01)

eHealth in Treatment of Offenders in Forensic Mental Health: A Review of the Current State
by: Hanneke Kip, et al.
Published: (2018-02-01)

The Effect of Long-Term Second-Generation Antipsychotics Use on the Metabolic Syndrome Parameters in Jordanian Population
by: Osama Abo Alrob, et al.
Published: (2019-06-01)

The benefits of the Mediterranean diet in first episode psychosis patients taking antipsychotics
by: Emilia Vassilopoulou, et al.
Published: (2022-01-01)

Association of early maladaptive schemas and psychiatric disorders between sex offenders
by: N. Stepanova, et al.
Published: (2022-06-01)

Violent and non-violent offending in patients with schizophrenia: Exploring influences and differences via machine learning
by: Martina Sonnweber, et al.
Published: (2021-05-01)

Combination treatment with second generation antipsychotics other than clozapine
by: C. Schmidt-Kraepelin
Published: (2021-04-01)

Comparison of antipsychotic prescribing practices following failure of antipsychotic monotherapy in the acute care setting
by: Kaitlyn Morgan, PharmD, BCPP, et al.
Published: (2023-01-01)

Editorial: Machine learning in research on violence and general offending
by: Johannes Kirchebner, et al.
Published: (2023-05-01)

Escape and absconding among offenders with schizophrenia spectrum disorder – an explorative analysis of characteristics
by: Johannes Kirchebner, et al.
Published: (2021-03-01)

Offenders and non-offenders with schizophrenia spectrum disorders: Do they really differ in known risk factors for aggression?
by: Johannes Kirchebner, et al.
Published: (2023-04-01)